Exactus, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a EXDI research report →
About the company
Exactus, Inc. is a leading producer and supplier, specializing in ingredients derived from hemp as well as cutting-edge feminized hemp genetics. The company's offerings include feminized genetic strains rich in both cannabidiol (CBD) and high-cannabigerol (CBG).
- CEO
- Alvaro Daniel Alberttis
- IPO
- 2015
- HQ
- Delray Beach, FL, US
Get TickerSpark's AI analysis on EXDI
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $0
- P/E
- -0.30
- PEG
- -0.00
- P/S
- 0.00
- P/B
- -1.07
- EV/EBITDA
- -0.01
- Div Yield
- 0.00%
- Gross Margin
- -100.00%
- Op Margin
- -388.05%
- Net Margin
- -402.24%
- ROE
- -1825.27%
- ROIC
- 289.78%
Latest fiscal year · YoY change
- Revenue
- $2.72M+686.9%
- Gross Profit
- $-2,720,000-60.0%
- Op Income
- $-10,555,000
- Net Income
- $-10,941,000-12.9%
- EPS
- $-0.22+24.1%
- OCF Growth
- +88.0%
- FCF Growth
- +89.0%
- 52W High
- $3.33
- 52W Low
- $0.04
- 50D MA
- $1.42
- 200D MA
- $0.43
- Beta
- 4.32
- Avg Volume
- 15.90K
No earnings-call transcripts are available for EXDI yet.
of shares held by institutions
2 13F filers
Buy/sell ratio 2.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 30, 21 | Buttorff Leslie | other | 0 |
| Jun 30, 21 | 22nd Century Group, Inc. | other | 0 |
| Jan 22, 21 | Wert Lawrence | other | 3,500,000 |
| Jan 22, 21 | Alberttis Alvaro Daniel | other | 2,039,241 |
| Jan 22, 21 | Alberttis Alvaro Daniel | other | 2,500,000 |
| Jan 22, 21 | Johnson Andrew L. | other | 8,186,240 |
| Jan 22, 21 | Johnson Andrew L. | other | 3,500,000 |
| Feb 1, 20 | Puzder Ken | other | 250,000 |
| Jan 16, 20 | Alberttis Alvaro Daniel | other | 0 |
| Dec 18, 19 | Johnson Andrew L. | buy | 62,500 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our EXDI coverage
Recent articles, reports, and earnings notes.
No research on EXDI yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate EXDI report →Exactus Energy Celebrates 10-Year Anniversary with Launch of Exactus Engineering: Forward-Thinking Structural Engineer Services
globenewswire.com · May 6
Panacea Life Sciences plans to capitalize on popularity of Denver airport to sell its CBD products
proactiveinvestors.com · Oct 29
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.